Management of drug-induced movement disorders in psychiatry: an update

Management of drug-induced movement disorders in psychiatry: an update

Drug-induced movement disorders (DIMD) represent a variety of iatrogenic and clinically distinct movement disorders, including akathisia, tardive dyskinesia, dystonia, and Parkinsonism. DIMD remain a significant burden especially among certain patient populations receiving psychotropic medication. K...

Full description

Bibliographic Details
Main Authors:	Sekh Afrar Alam, Aparajeeta Baruah, Gopal Agarwal, Nilesh Mohite
Format:	Article
Language:	English
Published:	Academy Publisher 2016-07-01
Series:	Open Journal of Psychiatry and Allied Sciences
Subjects:	Akathisia Tardive Dyskinesia. Dystonia. Parkinsonism. Neuroleptic. Antidepressant. Tardive Dyskinesia Dystonia. Parkinsonism. Neuroleptic. Antidepressant. Dystonia Parkinsonism. Neuroleptic. Antidepressant. Parkinsonism Neuroleptic Antidepressant
Online Access:	http://ojpas.npage.de/get_file.php?id=30971961&vnr=864060

Similar Items

Scopolamine alleviates involuntary lingual movements: tardive dyskinesia or dystonia?
by: Hu JB, et al.
Published: (2017-08-01)

Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate
by: Francois-Pierre Joubert, et al.
Published: (2021-01-01)

Neuroleptic-induced tardive dystonia in young patients suffering from psychosis
by: Amey Yeshwant Angane, et al.
Published: (2022-01-01)

Antipsychotics and chronic dystonia at a Botulinum Toxin clinic
by: Mahlatse Thosago, et al.
Published: (2024-09-01)

Drug-Induced Movement Disorders and Its Associated Factors Among Patients Attending Treatment at Public Hospitals in Eastern Ethiopia
by: Misgana T, et al.
Published: (2020-08-01)

Early Remission in Focal Tardive Dystonia Associated with the Use of Neuroleptic Medication: A Rare Case Report and Review of Literature
by: Gulsen Aykol, et al.
Published: (2015-03-01)

Drug induced movement disorders /
by: Factor, Stewart A., 1956-, et al.
Published: (2005)

Bridging the gap between statistical significance and clinical relevance: A systematic review of minimum clinically important difference (MCID) thresholds of scales reported in movement disorders research
by: Biswamohan Mishra, et al.
Published: (2024-03-01)

Effects of neuroleptics and antidepressants on the cardiovascular system: literature review
by: V. Rutkauskas
Published: (2019-09-01)

Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic
by: Feldman M, et al.
Published: (2022-12-01)

Psychotropic drugs and bone
by: R.W. Gasser, et al.
Published: (2024-12-01)

Extrapyramidal side effects with nonantipsychotic medications
by: Jessa Koch, PharmD, BCPP, APh, et al.
Published: (2024-08-01)

Longitudinal Evaluation of the Effect of Tricyclic Antidepressants and Neuroleptics on the Course of Huntington’s Disease—Data from a Real World Cohort
by: Jannis Achenbach, et al.
Published: (2021-03-01)

Tardive Dyskinesia and Dystonia – Clinical Case Review and Grand Rounds
by: Satish Suhas, et al.
Published: (2022-04-01)

Parkinsonism Hyperpyrexia Syndrome Mimicking Fever of Unknown Origin in Advanced Parkinson’s Disease Patient
by: Saeromi Kim, et al.
Published: (2015-12-01)

Effects of music therapy on drug therapy of adult psychiatric outpatients: A pilot randomised controlled study
by: Mario Degli Stefani, et al.
Published: (2016-10-01)

Tardive dyskinesia
by: Violetta A. Tolmacheva
Published: (2021-11-01)

Acute dystonia after single dose of bupropion
by: Forouzan Elyasi, et al.
Published: (2016-01-01)

Dynamics of the quality of life of patients with tardive form of neuroleptic dyskinesia during botulinum therapy
by: L. A. Hublarova, et al.
Published: (2018-07-01)

Low dosage of aripiprazole induced neuroleptic malignant syndrome after interaction with other neuroleptic drugs
by: Albino Petrone, et al.
Published: (2013-09-01)

Case report: Pallidal deep brain stimulation for treatment of tardive dystonia/dyskinesia secondary to chronic metoclopramide medication
by: Johanna M. Nagel, et al.
Published: (2023-01-01)

Levosulpiride-induced neurological adverse effects: A prospective study from a tertiary care center
by: Jacob Joe
Published: (2020-01-01)

Suppression and treatment of Haloperidol induced extra-pyramidal side effects and anxiety syndrome by the coadministeration of red rice bran oil in rats
by: Farah Naz, et al.
Published: (2014-12-01)

MORPHOMETRIC ASPECTS OF NEUROLEPTIC CARDIOMYOPATHY MORPHOGENESIS
by: V. P. Volkov
Published: (2012-06-01)

Neuroleptic malignant syndrome: a diagnostic dilemma in an unconscious patient—a case report
by: Swati Jain, et al.
Published: (2022-11-01)

Drug-Induced Parkinsonism and Neuroleptic Malignant Syndrome: A Case Report
by: Alexey A. Tappakhov, et al.
Published: (2020-06-01)

Reversible splenial lesion syndrome in neuroleptic malignant syndrome.
by: Al-Edrus, Sharifah Aishah, et al.
Published: (2009)

Pharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson's disease modifier genes
by: Lior eGreenbaum, et al.
Published: (2015-02-01)

Neuroleptic Malignant Syndrome - review of pathophysiology, clinical presentation, differentiation and management
by: Karolina Strus, et al.
Published: (2024-05-01)

A Systematic Review of Oral Vertical Dyskinesia (“Rabbit” Syndrome)
by: Jamir Pitton Rissardo, et al.
Published: (2024-08-01)

A Fatal Case of Neuroleptic Malignant Syndrome After Paralytic Bowel in a Patient Taking Antiparkinson Medication
by: Domenico Campa, et al.
Published: (2016-06-01)

Pisa Syndrome Secondary to Drugs: A Scope Review
by: Jamir Pitton Rissardo, et al.
Published: (2024-07-01)

Treatment of tardive dyskinesia caused by long-term antipsychotic use: case reports and literature review
by: I. Pabarčiūtė, et al.
Published: (2020-12-01)

The use of sertraline to treat an adolescent of dystonia comorbid with major depressive disorder with psychotic features
by: Chia‐Chien Liu, et al.
Published: (2024-03-01)

A Low Clozapine Dose Improved Refractory Tardive Dystonia without Exacerbating Psychiatric Symptoms: A Case Report
by: Okamoto N, et al.
Published: (2021-04-01)

Neuroleptic Malign-like Syndrome Case Management in Intensive Care Unit
by: Kadir İDİN, et al.
Published: (2016-04-01)

Tardive Oromandibular Dystonia Induced by Trazodone: A Clinical Case and Management from the Perspective of the Dental Specialist
by: Nicolás P. Skarmeta, et al.
Published: (2022-09-01)

Therapy for depression in bipolar affective disorder
by: N. A. Tyuvina, et al.
Published: (2016-07-01)

Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats
by: Fernanda Fiel Peres, et al.
Published: (2016-09-01)

Neuroleptic malignant syndrome due to risperidone misdiagnosed as status epilepticus
by: Ali Ertug Arslankoylu, et al.
Published: (2011-06-01)